{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:50:52Z","timestamp":1789541452257,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00405-023-08336-8","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T10:02:56Z","timestamp":1700301776000},"page":"1807-1817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Residual nasal polyp tissue following dupilumab therapy is associated with periostin-associated fibrosis"],"prefix":"10.1007","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-1001","authenticated-orcid":false,"given":"Isao","family":"Suzaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2695-1472","authenticated-orcid":false,"given":"Yuki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1541-5172","authenticated-orcid":false,"given":"Sawa","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4466-7953","authenticated-orcid":false,"given":"Kojiro","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nunomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Izuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-4514","authenticated-orcid":false,"given":"Hitome","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,18]]},"reference":[{"key":"8336_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58:1\u2013464. https:\/\/doi.org\/10.4193\/Rhin20.600","journal-title":"Rhinology"},{"key":"8336_CR2","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamaoto.2020.1453","volume":"146","author":"JW Grayson","year":"2020","unstructured":"Grayson JW, Hopkins C, Mori E, Senior B, Harvey RJ (2020) Contemporary classification of chronic rhinosinusitis beyond polyps vs no polyps: a review. JAMA Otolaryngology-Head & Neck Surgery 146:831\u2013838. https:\/\/doi.org\/10.1001\/jamaoto.2020.1453","journal-title":"JAMA Otolaryngology-Head & Neck Surgery"},{"key":"8336_CR3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/all.12644","volume":"70","author":"T Tokunaga","year":"2015","unstructured":"Tokunaga T, Sakashita M, Haruna T et al (2015) Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study. Allergy 70:995\u20131003. https:\/\/doi.org\/10.1111\/all.12644","journal-title":"Allergy"},{"key":"8336_CR4","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.alit.2019.07.002","volume":"68","author":"S Fujieda","year":"2019","unstructured":"Fujieda S, Imoto Y, Kato Y et al (2019) Eosinophilic chronic rhinosinusitis. Allergol Int 68:403\u2013412. https:\/\/doi.org\/10.1016\/j.alit.2019.07.002","journal-title":"Allergol Int"},{"key":"8336_CR5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jaci.2020.01.027","volume":"145","author":"T Takabayashi","year":"2020","unstructured":"Takabayashi T, Schleimer RP (2020) Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin. J Allergy Clin Immunol 145:740\u2013750. https:\/\/doi.org\/10.1016\/j.jaci.2020.01.027","journal-title":"J Allergy Clin Immunol"},{"key":"8336_CR6","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/s0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394:1638\u20131650. https:\/\/doi.org\/10.1016\/s0140-6736(19)31881-1","journal-title":"Lancet"},{"key":"8336_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/all.14906","volume":"77","author":"S Fujieda","year":"2022","unstructured":"Fujieda S, Matsune S, Takeno S et al (2022) Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status. Allergy 77:186\u2013196. https:\/\/doi.org\/10.1111\/all.14906","journal-title":"Allergy"},{"key":"8336_CR8","unstructured":"(GINA) GIfA Global Strategy for Asthma Management and Prevention. GINA Updated Report 2022. Accessed 01 June 2023***"},{"key":"8336_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/all.13599","volume":"74","author":"ML Kowalski","year":"2019","unstructured":"Kowalski ML, Agache I, Bavbek S et al (2019) Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)-a EAACI position paper. Allergy 74:28\u201339. https:\/\/doi.org\/10.1111\/all.13599","journal-title":"Allergy"},{"key":"8336_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.anl.2019.04.002","volume":"46","author":"T Miwa","year":"2019","unstructured":"Miwa T, Ikeda K, Ishibashi T et al (2019) Clinical practice guidelines for the management of olfactory dysfunction\u2014secondary publication. Auris Nasus Larynx 46:653\u2013662. https:\/\/doi.org\/10.1016\/j.anl.2019.04.002","journal-title":"Auris Nasus Larynx"},{"key":"8336_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","volume":"131","author":"P Gevaert","year":"2013","unstructured":"Gevaert P, Calus L, Van Zele T et al (2013) Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 131:110-116.e111. https:\/\/doi.org\/10.1016\/j.jaci.2012.07.047","journal-title":"J Allergy Clin Immunol"},{"key":"8336_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jaci.2006.02.046","volume":"118","author":"G Takayama","year":"2006","unstructured":"Takayama G, Arima K, Kanaji T et al (2006) Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 118:98\u2013104. https:\/\/doi.org\/10.1016\/j.jaci.2006.02.046","journal-title":"J Allergy Clin Immunol"},{"key":"8336_CR13","doi-asserted-by":"publisher","first-page":"11450","DOI":"10.1038\/s41598-018-29612-2","volume":"8","author":"T Ninomiya","year":"2018","unstructured":"Ninomiya T, Noguchi E, Haruna T et al (2018) Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinitis with nasal polyps. Sci Rep 8:11450. https:\/\/doi.org\/10.1038\/s41598-018-29612-2","journal-title":"Sci Rep"},{"key":"8336_CR14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/all.15074","volume":"77","author":"A Kato","year":"2022","unstructured":"Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC (2022) Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy 77:812\u2013826. https:\/\/doi.org\/10.1111\/all.15074","journal-title":"Allergy"},{"key":"8336_CR15","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jaci.2022.02.016","volume":"149","author":"A Kato","year":"2022","unstructured":"Kato A, Schleimer RP, Bleier BS (2022) Mechanisms and pathogenesis of chronic rhinosinusitis. J Allergy Clin Immunol 149:1491\u20131503. https:\/\/doi.org\/10.1016\/j.jaci.2022.02.016","journal-title":"J Allergy Clin Immunol"},{"key":"8336_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.anl.2018.09.004","volume":"46","author":"T Nakayama","year":"2019","unstructured":"Nakayama T, Sugimoto N, Okada N et al (2019) JESREC score and mucosal eosinophilia can predict endotypes of chronic rhinosinusitis with nasal polyps. Auris Nasus Larynx 46:374\u2013383. https:\/\/doi.org\/10.1016\/j.anl.2018.09.004","journal-title":"Auris Nasus Larynx"},{"key":"8336_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4168\/aair.2018.10.5.490","volume":"10","author":"DK Kim","year":"2018","unstructured":"Kim DK, Kang SI, Kong IG et al (2018) Two-track medical treatment strategy according to the clinical scoring system for chronic rhinosinusitis. Allergy Asthma Immunol Res 10:490\u2013502. https:\/\/doi.org\/10.4168\/aair.2018.10.5.490","journal-title":"Allergy Asthma Immunol Res"},{"key":"8336_CR18","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00405-022-07679-y","volume":"280","author":"F Jansen","year":"2023","unstructured":"Jansen F, Becker B, Eden JK et al (2023) Dupilumab (Dupixent(\u00ae)) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany. Eur Arch Otorhinolaryngol 280:1741\u20131755. https:\/\/doi.org\/10.1007\/s00405-022-07679-y","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"8336_CR19","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.3390\/jcm11102684","volume":"11","author":"E De Corso","year":"2022","unstructured":"De Corso E, Settimi S, Montuori C et al (2022) Effectiveness of dupilumab in the treatment of patients with severe uncontrolled CRSwNP: a \u201creal-life\u201d observational study in the first year of treatment. J Clin Med 11:2684. https:\/\/doi.org\/10.3390\/jcm11102684","journal-title":"J Clin Med"},{"key":"8336_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/00016489.2019.1654131","volume":"139","author":"T Kashiwagi","year":"2019","unstructured":"Kashiwagi T, Tsunemi Y, Akutsu M, Nakajima I, Haruna S (2019) Postoperative evaluation of olfactory dysfunction in eosinophilic chronic rhinosinusitis\u2014comparison of histopathological and clinical findings. Acta Otolaryngol 139:881\u2013889. https:\/\/doi.org\/10.1080\/00016489.2019.1654131","journal-title":"Acta Otolaryngol"},{"key":"8336_CR21","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jaci.2010.02.020","volume":"125","author":"T Van Zele","year":"2010","unstructured":"Van Zele T, Gevaert P, Holtappels G et al (2010) Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 125:1069-1076.e1064. https:\/\/doi.org\/10.1016\/j.jaci.2010.02.020","journal-title":"J Allergy Clin Immunol"},{"key":"8336_CR22","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1002\/lary.25352","volume":"125","author":"MC Ecevit","year":"2015","unstructured":"Ecevit MC, Erdag TK, Dogan E, Sutay S (2015) Effect of steroids for nasal polyposis surgery: a placebo-controlled, randomized, double-blind study. Laryngoscope 125:2041\u20132045. https:\/\/doi.org\/10.1002\/lary.25352","journal-title":"Laryngoscope"},{"key":"8336_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaci.2006.03.012","volume":"118","author":"P Hissaria","year":"2006","unstructured":"Hissaria P, Smith W, Wormald PJ et al (2006) Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol 118:128\u2013133. https:\/\/doi.org\/10.1016\/j.jaci.2006.03.012","journal-title":"J Allergy Clin Immunol"},{"key":"8336_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jaci.2020.01.024","volume":"145","author":"J Mullol","year":"2020","unstructured":"Mullol J, Mari\u00f1o-S\u00e1nchez F, Valls M, Alobid I, Marin C (2020) The sense of smell in chronic rhinosinusitis. J Allergy Clin Immunol 145:773\u2013776. https:\/\/doi.org\/10.1016\/j.jaci.2020.01.024","journal-title":"J Allergy Clin Immunol"},{"key":"8336_CR25","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","volume":"7","author":"WW Stevens","year":"2019","unstructured":"Stevens WW, Peters AT, Tan BK et al (2019) Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract 7:2812-2820.e2813. https:\/\/doi.org\/10.1016\/j.jaip.2019.05.009","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8336_CR26","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jaip.2021.09.037","volume":"10","author":"J Mullol","year":"2022","unstructured":"Mullol J, Bachert C, Amin N et al (2022) Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 10:1086-1095.e1085. https:\/\/doi.org\/10.1016\/j.jaip.2021.09.037","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8336_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/alr.23073","volume":"13","author":"A Saraswathula","year":"2023","unstructured":"Saraswathula A, Liu MM, Kulaga H, Lane AP (2023) Chronic interleukin-13 expression in mouse olfactory mucosa results in regional aneuronal epithelium. Int Forum Allergy Rhinol 13:230\u2013241. https:\/\/doi.org\/10.1002\/alr.23073","journal-title":"Int Forum Allergy Rhinol"},{"key":"8336_CR28","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.1002\/lary.27112","volume":"128","author":"J Wu","year":"2018","unstructured":"Wu J, Chandra RK, Li P, Hull BP, Turner JH (2018) Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis. Laryngoscope 128:E304-e310. https:\/\/doi.org\/10.1002\/lary.27112","journal-title":"Laryngoscope"},{"key":"8336_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/alr.22499","volume":"10","author":"ZM Soler","year":"2020","unstructured":"Soler ZM, Yoo F, Schlosser RJ et al (2020) Correlation of mucus inflammatory proteins and olfaction in chronic rhinosinusitis. Int Forum Allergy Rhinol 10:343\u2013355. https:\/\/doi.org\/10.1002\/alr.22499","journal-title":"Int Forum Allergy Rhinol"},{"key":"8336_CR30","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1111\/all.13814","volume":"74","author":"K Izuhara","year":"2019","unstructured":"Izuhara K, Nunomura S, Nanri Y, Ono J, Takai M, Kawaguchi A (2019) Periostin: an emerging biomarker for allergic diseases. Allergy 74:2116\u20132128. https:\/\/doi.org\/10.1111\/all.13814","journal-title":"Allergy"},{"key":"8336_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/resp.12873","volume":"22","author":"I Suzaki","year":"2017","unstructured":"Suzaki I, Kawano S, Komiya K et al (2017) Inhibition of IL-13-induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC. Respirology 22:93\u2013100. https:\/\/doi.org\/10.1111\/resp.12873","journal-title":"Respirology"},{"key":"8336_CR32","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1164\/rccm.201510-2032PP","volume":"193","author":"K Izuhara","year":"2016","unstructured":"Izuhara K, Conway SJ, Moore BB et al (2016) Roles of periostin in respiratory disorders. Am J Respir Crit Care Med 193:949\u2013956. https:\/\/doi.org\/10.1164\/rccm.201510-2032PP","journal-title":"Am J Respir Crit Care Med"},{"key":"8336_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4193\/Rhino16.215","volume":"55","author":"JA Ebenezer","year":"2017","unstructured":"Ebenezer JA, Christensen JM, Oliver BG et al (2017) Periostin as a marker of mucosal remodelling in chronic rhinosinusitis. Rhinology 55:234\u2013241. https:\/\/doi.org\/10.4193\/Rhino16.215","journal-title":"Rhinology"},{"key":"8336_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2332\/allergolint.11-OA-0370","volume":"61","author":"A Ishida","year":"2012","unstructured":"Ishida A, Ohta N, Suzuki Y et al (2012) Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol Int 61:589\u2013595. https:\/\/doi.org\/10.2332\/allergolint.11-OA-0370","journal-title":"Allergol Int"},{"key":"8336_CR35","doi-asserted-by":"publisher","unstructured":"Izuhara K, Fujieda S, Ohta N (2023) The functional role and the clinical application of periostin in chronic rhinosinusitis. Expert Rev Clin Immunol:1\u201310. https:\/\/doi.org\/10.1080\/1744666x.2023.2192928","DOI":"10.1080\/1744666x.2023.2192928"},{"key":"8336_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2022.103561","volume":"43","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Liu J, Xie L, Cao W, Ma F, Zhang Y (2022) Tissue eosinophils and mucous inflammatory cytokines for the evaluation of olfactory recovery after endoscopic sinus surgery in patients with nasal polyposis. Am J Otolaryngol 43:103561. https:\/\/doi.org\/10.1016\/j.amjoto.2022.103561","journal-title":"Am J Otolaryngol"},{"key":"8336_CR37","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/alr.22407","volume":"9","author":"SK Mueller","year":"2019","unstructured":"Mueller SK, Wendler O, Nocera A et al (2019) Escalation in mucus cystatin 2, pappalysin-A, and periostin levels over time predict need for recurrent surgery in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 9:1212\u20131219. https:\/\/doi.org\/10.1002\/alr.22407","journal-title":"Int Forum Allergy Rhinol"},{"key":"8336_CR38","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.jaci.2017.07.031","volume":"140","author":"K Jonstam","year":"2017","unstructured":"Jonstam K, Westman M, Holtappels G, Holweg CTJ, Bachert C (2017) Serum periostin, IgE, and SE-IgE can be used as biomarkers to identify moderate to severe chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 140:1705-1708.e1703. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.031","journal-title":"J Allergy Clin Immunol"},{"key":"8336_CR39","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/alr.22964","volume":"12","author":"C Bachert","year":"2022","unstructured":"Bachert C, Corren J, Lee SE et al (2022) Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trials. Int Forum Allergy Rhinol 12:1191\u20131195. https:\/\/doi.org\/10.1002\/alr.22964","journal-title":"Int Forum Allergy Rhinol"},{"key":"8336_CR40","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1177\/1945892419860634","volume":"33","author":"X Feng","year":"2019","unstructured":"Feng X, Payne SC, Borish L, Steinke JW (2019) Differential expression of extracellular matrix components in nasal polyp endotypes. Am J Rhinol Allergy 33:665\u2013670. https:\/\/doi.org\/10.1177\/1945892419860634","journal-title":"Am J Rhinol Allergy"},{"key":"8336_CR41","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/lary.21969","volume":"121","author":"SC Payne","year":"2011","unstructured":"Payne SC, Early SB, Huyett P, Han JK, Borish L, Steinke JW (2011) Evidence for distinct histologic profile of nasal polyps with and without eosinophilia. Laryngoscope 121:2262\u20132267. https:\/\/doi.org\/10.1002\/lary.21969","journal-title":"Laryngoscope"},{"key":"8336_CR42","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.otohns.2007.07.036","volume":"137","author":"JW Kim","year":"2007","unstructured":"Kim JW, Hong SL, Kim YK, Lee CH, Min YG, Rhee CS (2007) Histological and immunological features of non-eosinophilic nasal polyps. Otolaryngol Head Neck Surg 137:925\u2013930. https:\/\/doi.org\/10.1016\/j.otohns.2007.07.036","journal-title":"Otolaryngol Head Neck Surg"},{"key":"8336_CR43","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2500\/ajra.2017.31.4423","volume":"31","author":"SH Shin","year":"2017","unstructured":"Shin SH, Kim YH, Ye MK, Choi SY (2017) Immunopathologic characteristics of nasal polyps in adult Koreans: a single-center study. Am J Rhinol Allergy 31:168\u2013173. https:\/\/doi.org\/10.2500\/ajra.2017.31.4423","journal-title":"Am J Rhinol Allergy"},{"key":"8336_CR44","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/alr.22780","volume":"11","author":"C Hopkins","year":"2021","unstructured":"Hopkins C, Wagenmann M, Bachert C et al (2021) Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 11:1087\u20131101. https:\/\/doi.org\/10.1002\/alr.22780","journal-title":"Int Forum Allergy Rhinol"},{"key":"8336_CR45","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.jaci.2021.11.023","volume":"149","author":"JA Poposki","year":"2022","unstructured":"Poposki JA, Klingler AI, Stevens WW et al (2022) Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 149:1666\u20131674. https:\/\/doi.org\/10.1016\/j.jaci.2021.11.023","journal-title":"J Allergy Clin Immunol"},{"key":"8336_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaci.2021.03.024","volume":"148","author":"T Delemarre","year":"2021","unstructured":"Delemarre T, Bochner BS, Simon HU, Bachert C (2021) Rethinking neutrophils and eosinophils in chronic rhinosinusitis. J Allergy Clin Immunol 148:327\u2013335. https:\/\/doi.org\/10.1016\/j.jaci.2021.03.024","journal-title":"J Allergy Clin Immunol"},{"key":"8336_CR47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jaci.2020.08.036","volume":"147","author":"T Delemarre","year":"2021","unstructured":"Delemarre T, Holtappels G, De Ruyck N et al (2021) A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 147:179-188.e172. https:\/\/doi.org\/10.1016\/j.jaci.2020.08.036","journal-title":"J Allergy Clin Immunol"},{"key":"8336_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","volume":"147","author":"C Bachert","year":"2021","unstructured":"Bachert C, Han JK, Wagenmann M et al (2021) EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management. J Allergy Clin Immunol 147:29\u201336. https:\/\/doi.org\/10.1016\/j.jaci.2020.11.013","journal-title":"J Allergy Clin Immunol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-023-08336-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-023-08336-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-023-08336-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T12:05:04Z","timestamp":1710504304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-023-08336-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,18]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["8336"],"URL":"https:\/\/doi.org\/10.1007\/s00405-023-08336-8","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,18]]},"assertion":[{"value":"24 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I.S.: Sanofi\u2014speaker fee and research grant. K.H.: Sanofi\u2014speaker fee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This prospective, open-label observational study was approved by the ethical committee of Showa University (approval number 3351, approval date 4 January 2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for the publication of patients\u2019 clinical details and clinical images was obtained from the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}